Stocklytics Platform
Asset logo for symbol IMCR
Immunocore Holdings plc
IMCR69
$31.12arrow_drop_down0.88%-$0.27
High Growth
Asset logo for symbol IMCR
IMCR69

$31.12

arrow_drop_down0.88%

Income Statement (IMCR)

itemDec 2024Sep 2024Jun 2024Mar 2024Dec 2023
EBIT-$16.44M-$9.53M-$17.00M-$21.20M-$18.85M
EBITDA-$15.27M-$8.50M-$16.01M-$20.19M-$18.73M
gross Profit$83.72M$79.80M$73.69M$70.25M$105.88M
NET Income-$23.77M$8.73M-$11.61M-$24.43M-$26.41M
total Revenue$84.05M$80.24M$75.40M$70.50M$105.63M

Balance Sheet (IMCR)

itemDec 2024Sep 2024Jun 2024Mar 2024Dec 2023
cash Equivalents-----
net Debt-$23.00M-$56.70M-$32.03M-$360.04M-$358.59M
stockholders Equity$360.71M$377.82M$359.13M$359.53M$368.84M
total Assets$1.00B$1.08B$1.02B$993.98M$597.00M
total Debt$432.72M$481.06M$472.95M$472.77M$84.03M
total Liabilities$648.79M$706.81M$664.22M$634.45M$228.15M

Cash Flow (IMCR)

itemDec 2024Sep 2024Jun 2024Mar 2024Dec 2023
financing Cash Flow-$51.51M$198.00K-$818.00K$396.01M$22.85M
free Cash Flow-$17.53M$20.29M$23.14M-$5.01M-$11.43M
investing Cash Flow-----
operating Cash Flow-$13.95M$21.12M$23.47M-$4.58M-$10.84M

Immunocore Holdings plc (IMCR) Financials

The income statement for Immunocore Holdings plc (IMCR) provides information about the company's revenues, expenses, and profits over a given period of time. It includes the gross profit, which is the total revenue minus the cost of goods sold. The net income from stockholders is the profit that remains after deducting taxes and other expenses. The total revenue represents the sum of all sales and other income generated by the company. The ebit, or earnings before interest and taxes, is a measure of the company's profitability. Ebitda, or earnings before interest, taxes, depreciation, and amortization, is another measure of profitability that excludes non-cash expenses. These financial figures are important in evaluating the financial performance of Immunocore Holdings plc.
The balance sheet for Immunocore Holdings plc (IMCR) provides a snapshot of the company's assets, liabilities, and stockholders' equity at a specific point in time. Total assets represents the sum of all tangible and intangible assets owned by the company. Total liabilities includes both short-term and long-term obligations owed by the company. Stockholders' equity represents the ownership interest in the company held by its shareholders. Cash equivalents are highly liquid assets that can be readily converted into cash. Net debt is the difference between a company's total debt and its cash and cash equivalents. These financial figures provide insight into the financial health and stability of Immunocore Holdings plc.
add Immunocore Holdings plc to watchlist

Keep an eye on Immunocore Holdings plc

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Take Your Investments to a Whole New Level